33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.63%
Revenue growth under 50% of FLNC's 124.89%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.06%
Gross profit growth under 50% of FLNC's 155.92%. Michael Burry would be concerned about a severe competitive disadvantage.
4.87%
EBIT growth above 1.5x FLNC's 1.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
4.87%
Operating income growth above 1.5x FLNC's 1.09%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
9.45%
Net income growth under 50% of FLNC's 33.17%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.14%
EPS growth under 50% of FLNC's 34.38%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.14%
Diluted EPS growth under 50% of FLNC's 34.38%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.88%
Share count expansion well above FLNC's 0.76%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.88%
Diluted share count expanding well above FLNC's 0.76%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
24.20%
OCF growth 1.25-1.5x FLNC's 16.18%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
27.27%
FCF growth 1.25-1.5x FLNC's 20.01%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-26.87%
Negative 10Y revenue/share CAGR while FLNC stands at 202.86%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.87%
Negative 5Y CAGR while FLNC stands at 202.86%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-26.87%
Negative 3Y CAGR while FLNC stands at 202.86%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
60.31%
Positive long-term OCF/share growth while FLNC is negative. John Neff would see a structural advantage in sustained cash generation.
60.31%
Positive OCF/share growth while FLNC is negative. John Neff might see a comparative advantage in operational cash viability.
60.31%
Positive 3Y OCF/share CAGR while FLNC is negative. John Neff might see a big short-term edge in operational efficiency.
1.38%
Below 50% of FLNC's 55.04%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1.38%
Below 50% of FLNC's 55.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
1.38%
Below 50% of FLNC's 55.04%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.79%
Firm’s AR is declining while FLNC shows 52.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.99%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.03%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.00%
We’re deleveraging while FLNC stands at 6.56%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
2.10%
R&D dropping or stable vs. FLNC's 17.69%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.53%
SG&A declining or stable vs. FLNC's 5.29%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.